Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep
Henrik Zetterberg(University of Wisconsin–Madison), Daniela Meloni(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Alessandra Favole(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Maurizio Pocchiari(Istituto Superiore di Sanità), Elena Bozzetta(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Cristiano Corona(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Maria C. Cavarretta(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Francesco Ingravalle(Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 25
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k